Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline
Authors: Lei Yu, Robert J. Dawe, Patricia A. Boyle, Chris Gaiteri, Jingyun Yang, Aron S. Buchman, Julie A. Schneider, Konstantinos Arfanakis, Philip L. De Jager, David A. Bennett
Journal: JAMA Neurology (2017)

<h3>Importance</h3> Alteration of ex vivo magnetic resonance imaging transverse relaxation is associated with late-life cognitive decline even after controlling for common neuropathologic conditions. However, the underlying neurobiology of this association is unknown. <h3>Objective</h3> To investigate the association between brain gene expression, DNA methylation, and alteration of magnetic resonance imaging transverse relaxation in late-life cognitive decline. <h3>Design, Setting, and Participants</h3> Data came from 2 community-based longitudinal cohort studies of aging and dementia, the Religious Orders Study, which began in 1993, and the Rush Memory and Aging Project, which began in 1997. All participants agreed to undergo annual clinical evaluations and to donate their brains after death. By October 24, 2016, a total of 1358 individuals had died and had brain autopsies that were approved by board-certified neuropathologists. Of those, 552 had undergone ex vivo imaging. The gene expression analysis was limited to 174 individuals with both imaging and brain RNA sequencing data. The DNA methylation analysis was limited to 225 individuals with both imaging and brain methylation data. <h3>Main Outcomes and Measures</h3> Maps of ex vivo magnetic resonance imaging transverse relaxation were generated using fast spin echo imaging. The target was a composite measure of the transverse relaxation rate (R<sub>2</sub>) that was associated with cognitive decline after controlling for common neuropathologic conditions. Next-generation RNA sequencing and DNA methylation data were generated using frozen tissue from the dorsolateral prefrontal cortex. Genome-wide association analysis was used to investigate gene expression and, separately, DNA methylation for signals associated with the R<sub>2</sub>measure. <h3>Results</h3> Of the 552 individuals with ex vivo imaging data, 394 were women and 158 were men, and the mean (SD) age at death was 90.4 (6.0) years. Four co-expressed genes (<i>PADI2</i>[EnsemblENSG00000117115],<i>ZNF385A</i>[EnsemblENSG00000161642],<i>PSD2</i>[EnsemblENSG00000146005], and<i>A2ML1</i>[EnsemblENSG00000166535]) were identified, of which higher expressions were associated with slower R<sub>2</sub>. The association of R<sub>2</sub>with cognitive decline was attenuated when the gene expression signals were added to the model, such that the mean (SE) coefficient of association was reduced from 0.028 (0.008) (<i>P</i> &lt; .001) to 0.019 (0.009) (<i>P</i> = .03). The DNA methylation scan did not detect a genome-wide significant signal, but it revealed an anticorrelation between R<sub>2</sub>and DNA methylation in many of the cytosine-guanine dinucleotides. <h3>Conclusions and Relevance</h3> Brain gene expression and DNA methylation dysregulations are implicated in the alteration of brain tissue properties associated with late-life cognitive decline above and beyond the influence of common neuropathologic conditions.